 Initial studies that showed ability of CD133-positive population to efficiently propagate tumor when injected into immune-compromised mice firstly were performed on brain tumors.However, subsequent studies have indicated the difficulty in isolating pure CSC populations.CD133+ melanoma cells are considered a subpopulation of CSC and play a critical role in recurrence.